Navigation Links
State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International
Date:3/4/2010

LONDON, March 4, 2010 /PRNewswire/ -- "What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

Sam Gandy, M.D., Ph.D. of Mount Sinai Alzheimer's Disease Research Center, New York, will address "New Treatment Developments" in Alzheimer's, including therapies that have the greatest potential for entering clinical practice in the next few years - bapineuzumab, latrepirdine, and gamma secretase inhibitors. He also will touch on intriguing science that may explain the link between Alzheimer's and diabetes.

"Neuroimaging Perspectives" is the topic of Prof. Frank Jessen of the University of Bonn, Germany. The presentation will cover recent advances in both magnetic resonance imaging (MRI) and positron emission tomography (PET) in Alzheimer's. In particular, how the two technologies have contributed substantially to both better diagnosis and understanding the progression of the disease.

Pieter Jelle Visser, M.D. of Maastricht University Medical Centre and VU University Medical Centre, Amsterdam, The Netherlands will cover "MCI and the Early Diagnosis of Alzheimer's Disease." Mild cognitive impairment (MCI) refers to cognitive impairment not severe enough to meet the criteria of dementia. Using biomarkers and cognitive testing, it is possible to estimate the risk that a person with MCI will progress to Alzheimer's. Visser will provide an overview of markers for Alzheimer's in people with MCI and discuss how they may prove useful in clinical research, earlier diagnosis and treatment.

Bengt Winblad, M.D., Ph.D., of the Karolinska Institutet, Stockholm and Karolinska University, Huddinge, Sweden, will speak on "Ongoing clinical trials in Alzheimer's disease."

The day's second plenary session will focus on the "Global Alzheimer's Movement." Other plenaries will focus on treatments without drugs, and best practices in dementia care. For more information, visit http://www.adi2010.org/

ADI is working closely with the Greek Association of Alzheimer's Disease and Related Disorders in organizing this conference.

Alzheimer's Disease International is an international federation of 71 Alzheimer associations around the world, in official relations with the World Health Organization. ADI's mission is to improve the quality of life of people with dementia and their families throughout the world. Please visit http://www.alz.co.uk/adi/.

Contacts:

Niles Frantz, Alzheimer's Association (Chicago), +1-312-335-5777, niles.frantz@alz.org

Marc Wortmann, Alzheimer's Disease International (London), +44-20-7981-0880, m.wortmann@alz.co.uk

SOURCE Alzheimer's Disease International

Back to top
'/>"/>
SOURCE Alzheimer's Disease International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website
2. New Provider of Tablet/Capsule Packaging Solutions For Offers State-of-the-Art Equipment In The United States & Mexico
3. Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website
4. UCSF Medical Center Orders Three RIVA Systems for State-of-the-Art Pharmacy Facility
5. Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care
6. Epilepsy patients caught in treatment gap are not getting state-of-the-art care
7. Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website
8. Bay Area Plastic Surgeon Reaches Out to Patients with New, State-of-the-Art Website
9. Nicky Hambleton-Jones Supports Launch of State-of-the-Art London Cosmetic Surgery Clinic
10. LASIK Eye Surgeons in San Diego Announce Launch of New, State-of-the-Art Website
11. The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: